Global Ophthalmic Drugs Market Size & Outlook, 2024-2030
Global ophthalmic drugs market, 2018-2030 (US$M)
Related Markets
Global ophthalmic drugs market highlights
- The global ophthalmic drugs market generated a revenue of USD 38,197.5 million in 2024 and is expected to reach USD 62,082.1 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 8.4% by 2030.
- In terms of segment, anti-vegf agents accounted for a revenue of USD 12,553.4 million in 2024.
- Gene & Cell Therapy is the most lucrative drug class segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 38,197.5 million |
| Market revenue in 2030 | USD 62,082.1 million |
| Growth rate | 8.4% (CAGR from 2025 to 2030) |
| Largest segment | Anti-vegf agents |
| Fastest growing segment | Gene & Cell Therapy |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anti-Allergy, Anti-VEGF agents, Anti-glaucoma, Gene & Cell Therapy, Anti-inflammatory |
Other key industry trends
- In terms of revenue, the North America accounted for 42.7% of the global ophthalmic drugs market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, India is the fastest growing regional market and is projected to reach USD 1,842.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Ophthalmic Drugs Market Scope
Ophthalmic Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global ophthalmic drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic drugs market will help companies and investors design strategic landscapes.
Anti-vegf agents was the largest segment with a revenue share of 32.86% in 2024. Horizon Databook has segmented the Global ophthalmic drugs market based on anti-allergy, anti-vegf agents, anti-glaucoma, gene & cell therapy, anti-inflammatory covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Ophthalmic Drugs Drug Class Outlook (Revenue, USD Million, 2018-2030)
- Anti-Allergy
- Anti-VEGF agents
- Anti-glaucoma
- Gene & Cell Therapy
- Others
- Anti-inflammatory
- Non-steroidal drugs
- Steroids
- Global Ophthalmic Drugs Disease Outlook (Revenue, USD Million, 2018-2030)
- Dry Eye
- Gels
- Eye solutions & suspensions
- Capsules & Tablets
- Eye drops
- Ointments
- Allergies
- Gels
- Eye solutions & suspensions
- Capsules & Tablets
- Eye drops
- Ointments
- Glaucoma
- Gels
- Eye solutions & suspensions
- Capsules & Tablets
- Eye drops
- Ointments
- Infection
- Gels
- Eye solutions & suspensions
- Capsules & Tablets
- Eye drops
- Ointments
- Retinal Disorders
- Gels
- Eye solutions & suspensions
- Capsules & Tablets
- Eye drops
- Ointments
- Uveitis
- Gels
- Eye solutions & suspensions
- Capsules & Tablets
- Eye drops
- Ointments
- Others
- Gels
- Eye solutions & suspensions
- Capsules & Tablets
- Eye drops
- Ointments
- Dry Eye
- Global Ophthalmic Drugs Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Topical
- Systemic
- Local Ocular
- Subconjunctival
- Intravitreal
- Retrobulbar
- Intracameral
- Global Ophthalmic Drugs Dosage Type Outlook (Revenue, USD Million, 2018-2030)
- Gels
- Eye solutions & suspensions
- Capsules & Tablets
- Eye drops
- Ointments
- Global Ophthalmic Drugs Product Type Outlook (Revenue, USD Million, 2018-2030)
- OTC drugs
- Prescription
- Global Ophthalmic Drugs Drug Type Outlook (Revenue, USD Million, 2018-2030)
- Branded Drugs
- Generic Drugs
Reasons to subscribe to Global ophthalmic drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global ophthalmic drugs market databook
-
Our clientele includes a mix of ophthalmic drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global ophthalmic drugs market , including forecasts for subscribers. This global databook contains high-level insights into Global ophthalmic drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global ophthalmic drugs market size, by regions, 2018-2030 (US$M)
Global ophthalmic drugs market share, by drug class, 2024 & 2030 (%, US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
